Hyperbaric Oxygen for Ulcerative Colitis
Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial
Sponsor: Dartmouth-Hitchcock Medical Center
Terminated
slow recruitment
Other terminated trials from Dartmouth-Hitchcock Medical Center
- Anaplastic Astrocytoma · Aug 2025
- Lumbar Puncture · Phase NA · Dec 2023
- Vaccine Hesitancy · Phase NA · Jul 2023
- Pituitary Macroadenoma · Phase NA · Jul 2023
- Depression, Bipolar · Phase NA · Sep 2022
More terminations from Dartmouth-Hitchcock Medical Center
Other Ulcerative Colitis trials with similar outcome
A PHASE2/PHASE3 clinical study on Ulcerative Colitis, this trial is terminated or withdrawn. The trial is conducted by Dartmouth-Hitchcock Medical Center and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE2_PHASE3
▶ Show 1 earlier version
-
Jan 2017 — May 2018 [monthly]
Terminated PHASE2_PHASE3
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dartmouth-Hitchcock Medical Center
- Mayo Clinic
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .